The first horse has a severe fibroblastic sarcoid on the pastern which has previously been treated with a combination of surgical debridement and the older static electroporation device. This resulted in improvement but not complete resolution.The veterinarians at the RVC are now receiving encouraging progress updates from the owner following TSE treatment: "Looking much better today, particularly after being exposed to the air for a few hours. It's contracting and melting back; less prominent visually."
Despite TSE having already been shown to result in complete remission of sarcoids, this case is special in so far as improvement has been seen despite previous treatment failure with static electrochemotherapy (ECT) and furthermore, the treatment was performed under standing sedation and nerve blocks without the need for general anaesthesia - a true first!
The second horse suffers from a large type B2 nodular sarcoid on the cheek. The latest update that the RVC received from the owners stated: "Just another update for you - Ted's sarcoid is continuing to shrink".
Veterinarians at the RVC equine referral hospital are very satisfied with the results from the first cases that they have treated with TSE, thus far, and will continue to provide us with further updates as they treat more patients.
"We are very happy that veterinarians in both
Facts:
About 2 % of horses develop sarcoids[1] and it is estimated that there are about 6 million horses in the EU alone[2]. If the clinical results from the evaluations continue to show these results on sarcoid in horses, this can become a major market segment where TSE seems to have a competitive advantage.
Pictures of both horses will be published on the Instagram page: https://www.instagram.com/tse.veterinary/
For further information please contact:
Phone: +46 (0)10-218 93 00
E-mail: ir@chemotech.se
Certified Adviser:
E-mail: certifiedadviser@redeye.se
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on
ChemoTech is a Swedish medical technology company based in
[1] https://thehorse.com/169559/facts-about-sarcoids-in-horses/
[2] https://food.ec.europa.eu/animals/live-animal-movements/equine-animals_en
https://news.cision.com/chemotech/r/tse-treatments-at-the-royal-veterinary-college-shows-very-promising-results,c3702327
https://mb.cision.com/Main/14967/3702327/1799837.pdf
https://news.cision.com/chemotech/i/shutterstock-695775589,c3136674
(c) 2023 Cision. All rights reserved., source